Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1974 1
1975 1
1979 1
1984 1
1986 1
1988 2
1989 2
1990 8
1991 6
1992 4
1993 2
1994 6
1995 3
1996 5
1997 13
1998 14
1999 22
2000 25
2001 29
2002 31
2003 43
2004 49
2005 45
2006 56
2007 73
2008 67
2009 94
2010 104
2011 144
2012 161
2013 183
2014 213
2015 201
2016 246
2017 203
2018 223
2019 230
2020 308
2021 287
2022 295
2023 296
2024 259

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,484 results

Results by year

Filters applied: . Clear all
Page 1
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma.
Kim CG, Hong MH, Kim D, Lee BH, Kim H, Ock CY, Kelly G, Bang YJ, Kim G, Lee JE, Kim C, Kim SH, Hong HJ, Park YM, Sim NS, Park H, Park JW, Lee CG, Kim KH, Park G, Jung I, Han D, Kim JH, Cha J, Lee I, Kang M, Song H, Oum C, Kim S, Kim S, Lim Y, Kim-Schulze S, Merad M, Yoon SO, Kim HJ, Koh YW, Kim HR. Kim CG, et al. Among authors: cha j. Clin Cancer Res. 2024 May 15;30(10):2097-2110. doi: 10.1158/1078-0432.CCR-23-3249. Clin Cancer Res. 2024. PMID: 38457288 Clinical Trial.
Multi-targeted therapy resistance via drug-induced secretome fucosylation.
Aldonza MBD, Cha J, Yong I, Ku J, Sinitcyn P, Lee D, Cho RE, Delos Reyes RD, Kim D, Kim S, Kang M, Ku Y, Park G, Sung HJ, Ryu HS, Cho S, Kim TM, Kim P, Cho JY, Kim Y. Aldonza MBD, et al. Among authors: cha j. Elife. 2023 Mar 24;12:e75191. doi: 10.7554/eLife.75191. Elife. 2023. PMID: 36961502 Free PMC article.
Prevalence of Mutations in Mendelian Stroke Genes in Early Onset Stroke Patients.
Park HK, Lee KJ, Park JM, Kang K, Lee SJ, Kim JG, Cha JK, Kim DH, Han MK, Kang J, Kim BJ, Park TH, Park MS, Lee KB, Lee J, Hong KS, Cho YJ, Lee BC, Yu KH, Oh MS, Kim JT, Choi KH, Kim DE, Ryu WS, Choi JC, Kwon JH, Kim WJ, Shin DI, Sohn SI, Hong JH, Lee J, Lee K, Song J, Bae JS, Cheong HS, Debette S, Bae HJ. Park HK, et al. Among authors: cha jk. Ann Neurol. 2023 Apr;93(4):768-782. doi: 10.1002/ana.26575. Epub 2023 Jan 16. Ann Neurol. 2023. PMID: 36541592
Molecular biology of Huntington's disease.
McFarland KN, Cha JH. McFarland KN, et al. Among authors: cha jh. Handb Clin Neurol. 2011;100:25-81. doi: 10.1016/B978-0-444-52014-2.00003-3. Handb Clin Neurol. 2011. PMID: 21496570 Review.
3,484 results